>>Another article about it:
>>
[quoted text clipped - 8 lines]
>>guaiacolsulfonate. (No idea what that second ingredient does, but with the
>>guai in the name, I suspect it's similar.)
Correct.
> Ah so they got around the FDA's prohibition of "single-ingredient guaifenesin"
> by adding a nominal amount of a second ingredient!
But then they fell right into the FDA's other trap. Adding a second
ingredient makes Humibid LA into a "new drug," meaning that the
manufacturer has to submit an application before the drug can be sold:
http://www.fda.gov/foi/warning_letters/g4569d.htm

Signature
Steven D. Litvintchouk
Email: sdlitvin@earthlinkNOSPAM.net
Remove the NOSPAM before replying to me.
MS - 13 Nov 2004 17:44 GMT
> But then they fell right into the FDA's other trap. Adding a second
> ingredient makes Humibid LA into a "new drug," meaning that the
> manufacturer has to submit an application before the drug can be sold:
I think it's been approved and is available.
I wonder if the new ingredient really adds any efficacy, or is only to get
it by the FDA.